Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma.
Level 5 - mechanism / opinion, no new human data
Animal experiment without human subjects
PubMed 38060815 · doi:10.1089/cell.2023.0074
What was done
Mice with glaucoma-induced vision damage received gene therapy expressing the transcription factors Oct4, Sox2, and Klf4 (OSK) delivered via a doxycycline-inducible Tet-On adeno-associated virus (AAV) system. The investigators evaluated continuous versus cyclic OSK expression over a year-long period to track therapeutic efficacy, duration of vision recovery after doxycycline withdrawal, and long-term safety (retinal structure and body weight) for up to 21 months.
What was found
Two months of OSK expression fully restored impaired vision in glaucomatous mice, and continuous expression sustained this recovery for 11 months. Following doxycycline withdrawal, viral transcription returned to baseline at 4 weeks; significant visual improvements persisted for 1 month after cessation before gradually waning, though vision remained above pre-treatment baseline. Continuous OSK expression for 21 months caused no adverse effects on retinal architecture or body weight. The abstract reports no numerical values, variance estimates, or sample sizes.
Why it matters
This study demonstrates that partial epigenetic reprogramming via OSK can provide long-lasting functional recovery of vision in an experimental neurodegenerative disease model without apparent long-term oncogenic or structural toxicity.
Limits
The study was conducted exclusively in a mouse model of glaucoma, meaning human translatability and safety remain untested. The abstract omits sample sizes, exact visual performance metrics, statistical variance, and specific control group details.
Cited by
- supports Introducing three specific genes into the optic nerve and activating them for 6 to 8 weeks resets the cellular age of the nerves by approximately 75%.
- partial David Sinclair's group has successfully performed age reversal interventions in non-human primates (monkeys).
- context Researchers have successfully cured total blindness in monkeys, restoring their sight within six weeks.